A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Aime Franco, PhD, quietly battled cancer throughout her undergraduate years at the University of Connecticut. But even as she...
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
The lower premiums associated with high-deductible health plans may end up costing cancer patients in the long run.
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
“Easing the Pain” tells the story of cancer patients’ experiences dealing with pain and best practices for pain management....
Many things come to mind at the mention of New Orleans—jazz, Cajun food, po’ boys, and French-inspired houses with...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
On April 19, Sven Bilke, PhD, staff scientist in the Genetics Branch of the National Cancer Institute, discussed his...
During a conference known for its emphasis on basic and translational science, a panel discussion on the Affordable Care...